Rising volume of post-market clinical trials, increasing adverse drug reaction (ADR) reporting, and stringent global health authority mandates are driving rapid investment across the global Pharmacovigilance Market. Industry evaluations from Market Research Future indicate that the market is projected to reach USD 32.13 billion by 2035, growing at a strong compound annual growth rate (CAGR) of...